Clinical Trials with Combination of Cytokine-Induced Killer Cells and Dendritic Cells for Cancer Therapy
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Clinical Trials with Combination of Cytokine-Induced Killer Cells and Dendritic Cells for Cancer Therapy
Authors
Keywords
-
Journal
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
Volume 20, Issue 17, Pages 4307
Publisher
MDPI AG
Online
2019-09-04
DOI
10.3390/ijms20174307
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Clinical efficacy and safety of CIK plus radiotherapy for lung cancer: A meta-analysis of 16 randomized controlled trials
- (2018) Zheng Xiao et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Lenvatinib versus sorafenib in first-line treatment of patients with unresectable hepatocellular carcinoma: a randomised phase 3 non-inferiority trial
- (2018) Masatoshi Kudo et al. LANCET
- Pembrolizumab in patients with advanced hepatocellular carcinoma previously treated with sorafenib (KEYNOTE-224): a non-randomised, open-label phase 2 trial
- (2018) Andrew X Zhu et al. LANCET ONCOLOGY
- Cabozantinib in Patients with Advanced and Progressing Hepatocellular Carcinoma
- (2018) Ghassan K. Abou-Alfa et al. NEW ENGLAND JOURNAL OF MEDICINE
- 2003–2013, a valuable study: Autologous tumor lysate-pulsed dendritic cell immunotherapy with cytokine-induced killer cells improves survival in stage IV breast cancer
- (2017) Mao Lin et al. IMMUNOLOGY LETTERS
- NKG2D: A versatile player in the immune system
- (2017) Vedrana Jelenčić et al. IMMUNOLOGY LETTERS
- Clinical trials of CAR-T cells in China
- (2017) Bingshan Liu et al. Journal of Hematology & Oncology
- Chimeric antigen receptor T cells: a novel therapy for solid tumors
- (2017) Shengnan Yu et al. Journal of Hematology & Oncology
- Regorafenib for patients with hepatocellular carcinoma who progressed on sorafenib treatment (RESORCE): a randomised, double-blind, placebo-controlled, phase 3 trial
- (2017) Jordi Bruix et al. LANCET
- Nivolumab in patients with advanced hepatocellular carcinoma (CheckMate 040): an open-label, non-comparative, phase 1/2 dose escalation and expansion trial
- (2017) Anthony B El-Khoueiry et al. LANCET
- Effect and safety of cytokine-induced killer (CIK) cell immunotherapy in patients with breast cancer
- (2017) Jianxin Hu et al. MEDICINE
- Adjuvant immunotherapy of dendritic cells and cytokine-induced killer cells is safe and enhances chemotherapy efficacy for multiple myeloma in China: a meta-analysis of clinical trials
- (2017) Yan Wang et al. Drug Design Development and Therapy
- Autologous transplantation of cytokine-induced killer cells as an adjuvant therapy for hepatocellular carcinoma in Asia: an update meta-analysis and systematic review
- (2017) Xiu-Rong Cai et al. Oncotarget
- Phase II/III Study of Radiofrequency Ablation Combined with Cytokine-Induced Killer Cells Treating Colorectal Liver Metastases
- (2016) Xiaodong Li et al. CELLULAR PHYSIOLOGY AND BIOCHEMISTRY
- Adjuvant immunotherapy with autologous cytokine-induced killer cells for hepatocellular carcinoma patients after curative resection, a systematic review and meta-analysis
- (2016) Haiqing Wang et al. DIGESTIVE AND LIVER DISEASE
- Interleukin-15 enhances cytokine induced killer (CIK) cytotoxic potential against epithelial cancer cell lines via an innate pathway
- (2016) Paola Iudicone et al. HUMAN IMMUNOLOGY
- Primary analysis for clinical efficacy of immunotherapy in patients with pancreatic cancer
- (2016) Linghua Chen et al. Immunotherapy
- Adoptive immunotherapy with interleukin-2 & induced killer cells in non-small cell lung cancer: A systematic review & meta-analysis
- (2016) Kehu Yang et al. INDIAN JOURNAL OF MEDICAL RESEARCH
- TACE combined with dendritic cells and cytokine-induced killer cells in the treatment of hepatocellular carcinoma: A meta-analysis
- (2016) Guangzhi He et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Implication of combined PD-L1/PD-1 blockade with cytokine-induced killer cells as a synergistic immunotherapy for gastrointestinal cancer
- (2016) Congqi Dai et al. Oncotarget
- Phase III randomized trial of autologous cytokine-induced killer cell immunotherapy for newly diagnosed glioblastoma in korea
- (2016) Doo-Sik Kong et al. Oncotarget
- Retargeting cytokine-induced killer cell activity by CD16 engagement with clinical-grade antibodies
- (2016) Elisa Cappuzzello et al. OncoImmunology
- Cytokine induced killer cell-based immunotherapies in patients with different stages of renal cell carcinoma
- (2015) Xuan Zhao et al. CANCER LETTERS
- Adjuvant Immunotherapy With Autologous Cytokine-Induced Killer Cells for Hepatocellular Carcinoma
- (2015) Joon Hyeok Lee et al. GASTROENTEROLOGY
- Ramucirumab versus placebo as second-line treatment in patients with advanced hepatocellular carcinoma following first-line therapy with sorafenib (REACH): a randomised, double-blind, multicentre, phase 3 trial
- (2015) Andrew X Zhu et al. LANCET ONCOLOGY
- CBTRUS Statistical Report: Primary Brain and Central Nervous System Tumors Diagnosed in the United States in 2008-2012
- (2015) Quinn T. Ostrom et al. NEURO-ONCOLOGY
- Loss of CX3CR1 increases accumulation of inflammatory monocytes and promotes gliomagenesis
- (2015) Xi Feng et al. Oncotarget
- A Positive Role of Cytokine-Induced Killer Cell Therapy on Gastric Cancer Therapy in a Chinese Population: A Systematic Meta-Analysis
- (2015) Kang Liu et al. MEDICAL SCIENCE MONITOR
- Pancreatic Adenocarcinoma
- (2015) David P. Ryan et al. NEW ENGLAND JOURNAL OF MEDICINE
- Multiple Cytotoxic Factors Involved in IL-21 Enhanced Antitumor Function of CIK Cells Signaled through STAT-3 and STAT5b Pathways
- (2014) S. Rajbhandary et al. Asian Pacific Journal of Cancer Prevention
- Adoptive cellular immunotherapy for the treatment of patients with breast cancer: A meta-analysis
- (2014) Zheng-Xu Wang et al. CYTOTHERAPY
- Direct involvement of CD56 in cytokine-induced killer–mediated lysis of CD56+ hematopoietic target cells
- (2014) Rut Valgardsdottir et al. EXPERIMENTAL HEMATOLOGY
- Cytokine-induced killer cells in the treatment of patients with renal cell carcinoma: a pooled meta-analysis
- (2014) Zheng-Xu Wang et al. Immunotherapy
- Cytokine-induced killer (CIK) cells in cancer immunotherapy: report of the international registry on CIK cells (IRCC)
- (2014) Leonard Christopher Schmeel et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- FOLFIRI plus cetuximab versus FOLFIRI plus bevacizumab as first-line treatment for patients with metastatic colorectal cancer (FIRE-3): a randomised, open-label, phase 3 trial
- (2014) Volker Heinemann et al. LANCET ONCOLOGY
- Adoptive Immunotherapy of Cytokine-Induced Killer Cell Therapy in the Treatment of Non-Small Cell Lung Cancer
- (2014) Min Wang et al. PLoS One
- Cord Blood–Derived and Peripheral Blood–Derived Cytokine-Induced Killer Cells Are Sensitive to Fas-Mediated Apoptosis
- (2013) Ludovic Durrieu et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- DNAM-1 control of natural killer cells functions through nectin and nectin-like proteins
- (2013) Lucas Ferrari de Andrade et al. IMMUNOLOGY AND CELL BIOLOGY
- Panitumumab–FOLFOX4 Treatment and RAS Mutations in Colorectal Cancer
- (2013) Jean-Yves Douillard et al. NEW ENGLAND JOURNAL OF MEDICINE
- Enhancement of tumor-associated antigen-specific T cell responses by radiofrequency ablation of hepatocellular carcinoma
- (2012) Eishiro Mizukoshi et al. HEPATOLOGY
- Adoptive Immunotherapy in Postoperative Hepatocellular Carcinoma: A Systemic Review
- (2012) Feng Xie et al. PLoS One
- Efficacy study of CyberKnife stereotactic radiosurgery combined with CIK cell immunotherapy for advanced refractory lung cancer
- (2012) YUAN-YUAN WANG et al. Experimental and Therapeutic Medicine
- Efficacy of transcatheter arterial chemoembolization combined with cytokine-induced killer cell therapy on hepatocellular carcinoma: a comparative study
- (2012) Ming-Zhi Hao et al. Chinese Journal of Cancer
- T cells of patients with myelodysplastic syndrome are frequently derived from the malignant clone
- (2011) Suzanne M. Vercauteren et al. BRITISH JOURNAL OF HAEMATOLOGY
- Global cancer statistics
- (2011) Ahmedin Jemal et al. CA-A CANCER JOURNAL FOR CLINICIANS
- The cytotoxic potential of interleukin-15-stimulated cytokine-induced killer cells against leukemia cells
- (2011) Eva Rettinger et al. CYTOTHERAPY
- The brain tumor microenvironment
- (2011) Nikki A. Charles et al. GLIA
- Integrated Genomic Analysis Identifies Clinically Relevant Subtypes of Glioblastoma Characterized by Abnormalities in PDGFRA, IDH1, EGFR, and NF1
- (2010) Roel G.W. Verhaak et al. CANCER CELL
- Pancreatic Cancer
- (2010) Manuel Hidalgo NEW ENGLAND JOURNAL OF MEDICINE
- Cytokine-induced killer cells are terminallydifferentiated activated CD8 cytotoxic T-EMRA lymphocytes
- (2009) Marta Franceschetti et al. EXPERIMENTAL HEMATOLOGY
- Alloreactivity and anti-tumor activity segregate within two distinct subsets of cytokine-induced killer (CIK) cells: implications for their infusion across major HLA barriers
- (2008) Dario Sangiolo et al. INTERNATIONAL IMMUNOLOGY
- Sorafenib in Advanced Hepatocellular Carcinoma
- (2008) Josep M. Llovet et al. NEW ENGLAND JOURNAL OF MEDICINE
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started